Clinical trial

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

NCT00266032 · Bayer, Industry · Completed

Key facts

NCT number NCT00266032
Title Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
Official title A Multicenter, Open, Randomized, Parallel Group Comparison to Assess the Safety and Efficacy of the Oral Contraceptive SH T00186D (0.02 mg Ethinylestradiol as Betadex Clathrate and 3 mg Drospirenone) in Two Variations of an Extended Regimen vs. a Standard Regimen (24 + 4 Days) in 1122 Healthy Female…
Lead sponsor Bayer, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Contraception
Intervention type Drug
Interventions Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300), Fixed extended treatment of EE20/DRSP (YAZ, Standard 24+4 treatment of EE20/DRSP (YAZ
Enrollment 1,166
Start date Dec 1, 2005
Primary completion Oct 1, 2008
Completion Oct 1, 2008
First posted Dec 15, 2005
Last update posted Nov 3, 2014
Countries Canada, Germany, Netherlands

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies